Jordi Xiol

Director/Miembro de la Junta en

NorthSea Therapeutics BV

Consumer Services

Health Technology

Finance

Perfil

Jordi Xiol is currently a Partner at Ysios Capital Partners SGEIC SA since 2019.
He is also a Board Member at NorthSea Therapeutics BV since 2021 and at SpliceBio SL since 2023.
Mr. Xiol completed his undergraduate degree at the University of Barcelona in 2007 and obtained a doctorate from The European Molecular Biology Laboratory.

Cargos activos de Jordi Xiol

Empresas	Cargo	Inicio
Ysios Capital Partners SGEIC SA Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.	Inversor de Capital Privado	01/06/2021
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Director/Miembro de la Junta	01/01/2023
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Director/Miembro de la Junta	01/12/2021

Todos los cargos activos de Jordi Xiol

Formación de Jordi Xiol.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jordi Xiol.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
University of Barcelona University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The European Molecular Biology Laboratory The European Molecular Biology Laboratory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ysios Capital Partners SGEIC SA Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.	Finance
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Health Technology
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Health Technology

Ver las conexiones de la empresa